Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kana, Veronika
RED4MS, NCT06430671 / 2022-000801-28: Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis	Recruiting	1/2	135	Europe	CLS12311 low, CLS12311 medium, CLS12311 high, uncoupled RBCs	Cellerys AG, Novartis, Scope International AG, Tetec AG, Jung Diagnostics GmbH	Relapsing-remitting Multiple Sclerosis (RRMS)	08/26	03/27